Andrés
Íñiguez Romo
Publicacións nas que colabora con Andrés Íñiguez Romo (27)
2023
-
Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial
International Journal of Cardiology, Vol. 391
-
Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530
2022
-
Clinical Features and Long-Term Outcomes in Very Young Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries
Journal of Interventional Cardiology, Vol. 2022
2021
-
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433
-
Percutaneous and surgical aortic valve replacement. Impact of volume and type of center on results
REC: Interventional Cardiology, Vol. 3, Núm. 2, pp. 103-111
-
Reemplazo valvular aórtico percutáneo y quirúrgico.: Influencia del volumen y del tipo de centro tratante en los resultados
REC: Interventional Cardiology, Vol. 3, Núm. 2, pp. 103-111
-
TAVI en la curva de aprendizaje en España. Resultados intrahospitalarios comparados con la sustitución valvular aórtica
REC: CardioClinics, Vol. 56, Núm. 4, pp. 242-249
-
TAVI in the learning curve in Spain. In-hospital results compared with aortic valve replacement
REC: CardioClinics, Vol. 56, Núm. 4, pp. 242-249
2020
-
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention
European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770
-
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects
European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
-
Management of myocardial infarction in the elderly. Insights from Spanish Minimum Basic Data Set
European Heart Journal: Acute Cardiovascular Care, Vol. 8, Núm. 3, pp. 242-251
2018
-
Alirocumab and cardiovascular outcomes after acute coronary syndrome
New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107
-
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score
International Journal of Cardiology, Vol. 254, pp. 10-15
-
Patterns of Inpatient Care and Readmission Rates (30-day, 3-month and 1-year) in Myocardial Infarction in Spain. Differences Between STEMI and NSTEMI
Revista Espanola de Cardiologia, Vol. 71, Núm. 9, pp. 757-758
-
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835
2017
-
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 176-185
-
Evolocumab and clinical outcomes in patients with cardiovascular disease
New England Journal of Medicine, Vol. 376, Núm. 18, pp. 1713-1722
-
Impacto en la mortalidad de diferentes sistemas de asistencia en red para el tratamiento del infarto agudo de miocardio con elevación del segmento ST. La experiencia de España
Revista Espanola de Cardiologia, Vol. 70, Núm. 3, pp. 155-161
-
Patterns of inpatient care for acute myocardial infarction and 30-day, 3-month and 1-year cardiac diseases readmission rates in Spain
International Journal of Cardiology, Vol. 230, pp. 14-20